New technology allows vital signs to be checked via webcam

Webcam software developed by a new Oxford University spin-out company will offer a simple, non-invasive way of monitoring patients' vital signs.

OxeHealth, set-up by the University's technology transfer company Isis Innovation, is working on software that will detect a patient's , respiratory rate and even in artificial light without the need for any physical contact or additional hardware. The firm, spun out of Oxford University's Institute of , will receive up to £500,000 in funding from IP Group.

'Our research has transformed the ubiquitous webcam into a non-contact sensor for monitoring the most important vital signs,' said Professor Tarassenko, Director of the Institute of Biomedical Engineering. 'Our close collaboration with biomedical scientists in the University and in the NHS Trust has enabled rapid translation from the lab to the ward. We believe that our webcam software offers a step change in the way that the health of individuals can be assessed in the home or the hospital.'

The software has been validated in a clinical study with patients in the Oxford Kidney Unit, showing that respiratory rate, and oxygen saturation can all be monitored accurately with a remote webcam.

Tom Hockaday, MD of Isis Innovation, said: 'OxeHealth's product has the potential to make major healthcare improvements by reducing the number of times patients need to visit the doctor, and allowing doctors to adjust treatments quickly in response to real-time monitoring.'

Oxford University Hospitals NHS Trust Chief Executive, Sir Jonathan Michael said: 'We are delighted that OxeHealth is the first spin-out directly linked with the Trust. The study in our Unit was essential to demonstrate that the technology works in a , for the benefit of patients. Oxehealth is another example of the many innovative opportunities which the partnership between the Trust and the University is making possible.'

Alan Aubrey, Chief Executive Officer of IP Group said: 'Digital health is an exciting and growing area and IP Group is pleased to support OxeHealth as it seeks to develop new products that could transform healthcare and patient monitoring.'

Over the coming months, OxeHealth will refine its technology for remote monitoring of Chronic Obstructive Pulmonary Disorder and other chronic disease patients in their homes. 

add to favorites email to friend print save as pdf

Related Stories

Spin-out targets better cancer treatment

Jan 25, 2012

A new Oxford University spin-out firm, Oxford Cancer Biomarkers Limited, is to develop technology to ensure that only patients who are likely to benefit from anti-cancer drugs will receive them and that the best treatment ...

Start-up finds online meaning

Feb 15, 2012

(PhysOrg.com) -- Software developed at Oxford University that accurately assesses what people mean from what they say online will provide a valuable ‘sentiment analysis’ tool for businesses, particularly ...

Hold the phone for vital signs

Oct 06, 2011

An iPhone app that measures the user's heart rate is not only a popular feature with consumers, but it sparked an idea for a Worcester Polytechnic Institute (WPI) researcher who is now turning smart phones, ...

Recommended for you

Doctor behind 'free radical' aging theory dies

Nov 25, 2014

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.